DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Dendronized PLGA nanoparticles with anionic carbosilane dendrons as antiviral agents against HIV infection
The development of novel strategies to prevent HIV-1 infection is of outstanding relevance. PLGA nanoparticles have become some of the most used nanosized materials for biomedical applications. Polyanionic carbosilane dendrimers and dendrons have shown potent and broad-spectrum anti-HIV-1 activity. Therefore, PLGA nanoparticles functionalized with carbosilane anionic dendrons through a carbodiimide-mediated reaction have been prepared with the aim of them becoming novel antiviral agents against HIV infection. The biocompatibility of the new dendronized nanoparticles has been explored in PBMC and HEC-1A cells. Both inhibition experiments showed differences between dendronized nanoparticles, free dendrons and PLGA nanoparticles. The results obtained with the dendronized nanoparticles indicate that these systems are powerful anti-HIV agents, compared to dendrons or dendrimers alone or PLGA NPs, suggesting an enhancement of their interaction with viral or cell receptors. The topology and size of these new systems could be responsible for the higher activity observed., This work has been supported by grants CTQ-2014-54004-P and CTQ2011-29336-CO3-O1 (from MINECO), CCG2014/EXP010 (from UAH), 2014-SGR-1655 (from Generalitat de Catalunya) and Consortium NANODENDMED ref S2011/BMD-2351 (CM). CIBER-BBN as an initiative funded by the VI National R&D&i Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. Fondo Europeo de Desarrollo Regional (FEDER), RETIC PT13/0010/0028, Fondo de Investigacion Sanitaria (FIS) (grant number PI13/02016, PI14/00882 (JLJ) and PI12/0014), Comunidad de Madrid (grant numbers S-2010/BMD-2332), CYTED 214RT0482 to HGUGM. This work has been (partially) funded by the RD12/0017/0037, project as part of the project as part of the Acción Estratégica en Salud, Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2008–2011 (HGUGM) and "Programa de Investigación de la Consejería de Sanidad de la Comunidad de Madrid” to JLJ. This work was supported partially by a Marie Curie International Research Staff Exchange Scheme Fellowship within the 7th European Community Framework Program, project No. PIRSES-GA-2012-316730 NANOGENE, co-financed by the Polish Ministry of Science and Higher Education (grant No. W21/7 PR/2013). Cristina Fornaguera acknowledges AGAUR for their Predoctoral Fellowship (grant FI-DGR 2012)., Peer reviewed
Project:
MINECO / FP7 CTQ2014-54004-P
,
EC 316730
DOI: http://hdl.handle.net/10261/333300, https://api.elsevier.com/content/abstract/scopus_id/84981513438
HANDLE: http://hdl.handle.net/10261/333300, https://api.elsevier.com/content/abstract/scopus_id/84981513438